To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CDKN2AIPNLTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
113 supporting clones for gene CDKN2AIPNL back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB480185 hippocampus .a-u 1 to 326 1 to 326   tiling clone,   326/340
(95 %)
1 diff
(99.8 %id)
BQ647323 hepatocellular carcinoma, cell line, Liver .a-u 1 to 951 15 to 983 exact     969/996
(97 %)
30 diff
(97.0 %id)
BQ647076 hepatocellular carcinoma, cell line, Liver .a-u 1 to 847 15 to 867 H17T H18M G19V R20G W21G ...     853/916
(93 %)
28 diff
(97.0 %id)
BI910278 leukocyte .a-u 8 to 731 1 to 746       746/747
(99 %)
32 diff
(95.8 %id)
TI_57236152   .a-u 8 to 731 36 to 781       746/782
(95 %)
32 diff
(96.0 %id)
CR612048 Neuroblastoma Cot 25-normalized .a-u 20 to 1306 1 to 1287       1287/1287
(100 %)
0 diff
(100 %id)
BX375313 Neuroblastoma Cot 25-normalized .a-u 20 to 1023 1 to 991       991/1044
(94 %)
24 diff
(97.8 %id)
CR616012 B cells (Ramos cell line) Cot 25-normalized .a-u 40 to 1346 1 to 1307   tiling clone,   1307/1307
(100 %)
0 diff
(100 %id)
BX385203   .a-u 40 to 675 1 to 635   fully sequenced,   635/635
(100 %)
1 diff
(99.9 %id)
BX096509 breast .a-u 50 to 549 1 to 500   AAA   500/500
(100 %)
0 diff
(100 %id)
TI_57182289   .a-u 71 to 834 25 to 786       762/786
(96 %)
6 diff
(99.3 %id)
BI771622 pooled lung and spleen .a-u 75 to 834 1 to 758       758/758
(100 %)
18 diff
(97.7 %id)
AW972455   .a-u 100 to 547 449 to 2     Submitted on the opposite strand 448/449
(99 %)
0 diff
(100 %id)
AA507417 breast .a-u 125 to 549 425 to 1       425/425
(100 %)
10 diff
(97.7 %id)
AA931998 carcinoid, lung .a-u 235 to 567 332 to 1       332/332
(100 %)
1 diff
(99.7 %id)
BX385202   .a-u 645 to 1345 700 to 1   fully sequenced,   700/700
(100 %)
6 diff
(99.2 %id)
BE396801 Burkitt lymphoma, lymph .a-u 651 to 1308 1 to 654       654/685
(95 %)
5 diff
(99.3 %id)
BE559678 Burkitt lymphoma, lymph .a-u 651 to 1360 1 to 717   AAA   717/717
(100 %)
28 diff
(96.1 %id)
BE560039 Burkitt lymphoma, lymph .a-u 653 to 1301 1 to 648       648/967
(67 %)
16 diff
(98.4 %id)
DB548926 hippocampus .a-u 911 to 1358 1 to 448   tiling clone, Submitted on the opposite strand 448/448
(100 %)
0 diff
(100 %id)
AA687163 germinal center B cell .a-u 967 to 1358 421 to 30   AAA   392/392
(100 %)
3 diff
(99.3 %id)
AW439849 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a-u 1263 to 1364 117 to 16   AAA   102/102
(100 %)
0 diff
(100 %id)
DT220850 brain .b 1 to 632 1 to 632   tiling clone,   632/632
(100 %)
2 diff
(99.7 %id)
NM_080656.2   .b 1 to 1252 1 to 1252   RefSeq, AAA   1252/1252
(100 %)
0 diff
(100 %id)
BM915804 amelanotic melanoma, cell line, skin .b 4 to 974 1 to 978       978/979
(99 %)
25 diff
(97.5 %id)
DR001648 fetal brain .b 6 to 672 1 to 668       668/668
(100 %)
8 diff
(98.9 %id)
BC008293 Lung, small cell carcinoma .b 10 to 1188 1 to 1179   available from MGC, AAA   1179/1196
(98 %)
8 diff
(99.4 %id)
CN366628 embryonic stem cells, DMSO-treated H9 cellline .b 10 to 500 1 to 491 D87H     491/491
(100 %)
2 diff
(99.6 %id)
BQ051208 large cell carcinoma, lung .b 10 to 793 6 to 793       788/1070
(73 %)
19 diff
(98.3 %id)
BM806855 lymph, lymphoma, cell line .b 11 to 793 1 to 786       786/1068
(73 %)
13 diff
(98.8 %id)
DN990551 brain, whole brain .b 11 to 373 7 to 369       363/369
(98 %)
8 diff
(97.9 %id)
ES313078 beard hair, skin .b 12 to 168 1 to 155       155/155
(100 %)
1 diff
(99.4 %id)
BG030687 breast, mammary adenocarcinoma, cell line .b 13 to 748 1 to 733       733/765
(95 %)
22 diff
(97.2 %id)
BU180826 large cell carcinoma, lung .b 14 to 759 1 to 749       749/897
(83 %)
17 diff
(98.2 %id)
BQ918403 sciatic nerve .b 16 to 882 11 to 890       880/916
(96 %)
26 diff
(97.2 %id)
BQ933592 sciatic nerve .b 16 to 806 11 to 810       800/905
(88 %)
21 diff
(97.7 %id)
CD722093 eye, lacrimal gland .b 17 to 603 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BQ670189 epidermoid carcinoma, cell line, salivary gland .b 18 to 744 1 to 730       730/989
(73 %)
6 diff
(99.4 %id)
BU163724 epidermoid carcinoma, cell line, salivary gland .b 18 to 806 1 to 790       790/906
(87 %)
8 diff
(99.2 %id)
BQ669822 epidermoid carcinoma, cell line, salivary gland .b 18 to 615 1 to 601 K112N     601/1013
(59 %)
19 diff
(98.2 %id)
BI599281 brain, hypothalamus .b 26 to 795 1 to 773 R40S     773/821
(94 %)
17 diff
(98.0 %id)
BM009568 amelanotic melanoma, cell line, skin .b 26 to 741 1 to 721 S116K *117L     721/1007
(71 %)
18 diff
(98.3 %id)
TI_59384325   .b 27 to 741 66 to 785 S116K *117L     720/1006
(71 %)
17 diff
(98.4 %id)
BI253294 cervical carcinoma cell line, cervix .b 28 to 794 1 to 766       766/914
(83 %)
8 diff
(99.2 %id)
BE265855 lung, small cell carcinoma .b 29 to 608 1 to 580       580/586
(98 %)
7 diff
(98.9 %id)
BE266659 lung, small cell carcinoma .b 29 to 490 1 to 462       462/462
(100 %)
0 diff
(100 %id)
EL949170 eyeball .b 30 to 546 36 to 553 V17C R18A Q19A A20C A21G ...     518/553
(93 %)
8 diff
(98.6 %id)
CN483972 eye .b 30 to 632 1 to 603       603/603
(100 %)
0 diff
(100 %id)
TI_45212131   .b 31 to 795 95 to 862 R40S     768/910
(84 %)
17 diff
(98.2 %id)
BQ425207 melanotic melanoma, skin .b 32 to 753 19 to 747       729/852
(85 %)
20 diff
(97.7 %id)
CR602620 Placenta Cot 25-normalized .b 33 to 1193 1 to 1161       1161/1161
(100 %)
0 diff
(100 %id)
DR157878 human embryonic stem cells differentiated toan early endodermal cell type .b 33 to 638 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BX335513 Placenta Cot 25-normalized .b 36 to 1173 1 to 1136 E25X Q26S F27S R28A S29P ... fully sequenced,   1136/1136
(100 %)
12 diff
(99.0 %id)
CR591520 Placenta Cot 25-normalized .b 38 to 1200 1 to 1163   tiling clone,   1163/1163
(100 %)
0 diff
(100 %id)
AL546127 placenta, Placenta Cot 25-normalized .b 38 to 883 1 to 844 Q19Z A20X Q26S F27S R28A ... fully sequenced,   844/844
(100 %)
3 diff
(99.7 %id)
BG484865 lung .b 41 to 689 1 to 667 E109A L110P M111Y K112*     667/820
(81 %)
34 diff
(95.9 %id)
BU166361 melanotic melanoma, skin .b 42 to 818 5 to 784       780/885
(88 %)
12 diff
(98.7 %id)
CR612735 B cells (Ramos cell line) Cot 25-normalized .b 46 to 1200 1 to 1155       1155/1155
(100 %)
0 diff
(100 %id)
CR737413 germinal center B cell .b 46 to 295 1 to 250       250/250
(100 %)
3 diff
(98.8 %id)
BX342935   .b 46 to 358 1 to 312   fully sequenced,   312/312
(100 %)
1 diff
(99.7 %id)
BX360490 Placenta Cot 25-normalized .b 47 to 1056 35 to 1035 E25D Q26S F27S R28A S29P ...     1001/1048
(95 %)
28 diff
(97.4 %id)
CN366630 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 49 to 691 6 to 648       643/648
(99 %)
10 diff
(98.5 %id)
BM551940 astrocytoma grade IV, cell line, brain .b 50 to 1117 1 to 1083       1083/1096
(98 %)
57 diff
(94.8 %id)
BQ066488 lymph, lymphoma, cell line .b 51 to 849 1 to 809       809/1054
(76 %)
22 diff
(98.0 %id)
BU159010 large cell carcinoma, lung .b 51 to 951 1 to 905       905/906
(99 %)
18 diff
(98.1 %id)
BQ220161 melanotic melanoma, skin .b 53 to 774 12 to 741       730/809
(90 %)
39 diff
(95.2 %id)
CV024055 mixed .b 54 to 212 1 to 159       159/159
(100 %)
6 diff
(96.3 %id)
CV026949 mixed .b 54 to 403 1 to 350       350/522
(67 %)
0 diff
(100 %id)
BE514973 adenocarcinoma cell line, ovary .b 56 to 646 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
CN366629 embryonic stem cells, DMSO-treated H9 cellline .b 57 to 645 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
BX439619 placenta .b 71 to 1145 1 to 1059   AAA   1059/1103
(96 %)
20 diff
(98.2 %id)
BE394950 endometrium, adenocarcinoma cell line, uterus .b 71 to 689 1 to 619       619/630
(98 %)
14 diff
(97.8 %id)
CR604625 Placenta Cot 25-normalized .b 73 to 1199 1 to 1127       1127/1127
(100 %)
0 diff
(100 %id)
BX336064 Placenta Cot 25-normalized .b 73 to 540 1 to 465   fully sequenced,   465/465
(100 %)
0 diff
(100 %id)
BE907041 epithelioid carcinoma, Pancreas .b 84 to 794 1 to 711       711/1060
(67 %)
20 diff
(98.2 %id)
CN366631 embryonic stem cells, DMSO-treated H9 cellline .b 151 to 631 5 to 486       482/486
(99 %)
13 diff
(97.4 %id)
AI341611 pooled germ cell tumors .b 201 to 644 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AW590901 pooled germ cell tumors .b 231 to 645 420 to 6       415/420
(98 %)
0 diff
(100 %id)
AI377680 pooled .b 232 to 651 431 to 12   AAA   420/420
(100 %)
0 diff
(100 %id)
AI214551 carcinoid, lung .b 282 to 735 1 to 454     Submitted on the opposite strand 454/454
(100 %)
7 diff
(98.5 %id)
BE502971 carcinoid, lung .b 282 to 776 1 to 493     Submitted on the opposite strand 493/493
(100 %)
7 diff
(98.6 %id)
AW008741 brain, glioblastoma (pooled) .b 289 to 533 245 to 1       245/245
(100 %)
4 diff
(98.4 %id)
BQ334022 marrow .b 296 to 867 571 to 1       571/594
(96 %)
25 diff
(95.8 %id)
AI261644 Kidney .b 305 to 649 345 to 1       345/345
(100 %)
0 diff
(100 %id)
BG210758   .b 311 to 666 22 to 372   AAA   351/372
(94 %)
6 diff
(98.4 %id)
BX396355 Placenta Cot 25-normalized .b 328 to 1193 867 to 1   fully sequenced,   867/867
(100 %)
5 diff
(99.5 %id)
BX342934   .b 328 to 1200 872 to 1   fully sequenced,   872/872
(100 %)
11 diff
(98.8 %id)
AA206864   .b 337 to 645 1 to 312   fully sequenced,   312/312
(100 %)
6 diff
(98.1 %id)
AA206865   .b 362 to 644 301 to 19   fully sequenced, AAA   283/283
(100 %)
1 diff
(99.7 %id)
BF827664 head_normal .b 363 to 863 4 to 503       500/508
(98 %)
20 diff
(96.1 %id)
BF828856 head_normal .b 364 to 860 502 to 7     Submitted on the opposite strand 496/516
(96 %)
1 diff
(99.9 %id)
BX109019 carcinoid, lung .b 371 to 863 493 to 1     Submitted on the opposite strand 493/493
(100 %)
6 diff
(98.8 %id)
BG195410   .b 383 to 537 1 to 157       157/168
(93 %)
6 diff
(96.5 %id)
CN366627 embryonic stem cells, DMSO-treated H9 cellline .b 391 to 950 10 to 570       561/570
(98 %)
6 diff
(99.0 %id)
BG181157 adenocarcinoma, cell line, Prostate .b 394 to 1125 1 to 728       728/731
(99 %)
9 diff
(98.8 %id)
BU621747 cell lines, Chondrosarcoma .b 398 to 1228 842 to 19   AAA   824/825
(99 %)
10 diff
(98.8 %id)
BX336063 Placenta Cot 25-normalized .b 510 to 1170 692 to 29   fully sequenced,   664/692
(95 %)
14 diff
(98.0 %id)
AW582738 testis .b 527 to 1026 498 to 1       498/498
(100 %)
7 diff
(98.6 %id)
AA489204 germinal center B cell .b 742 to 1232 496 to 6       491/496
(98 %)
0 diff
(100 %id)
BM997508 lung, Metastatic Chondrosarcoma .b 742 to 1252 530 to 19   tiling clone, AAA   512/512
(100 %)
1 diff
(99.9 %id)
AW003886 brain, glioblastoma (pooled) .b 775 to 1214 440 to 1       440/440
(100 %)
2 diff
(99.6 %id)
CF122690 CNCAP(3)T-225 cell line, Prostate .b 784 to 1228 70 to 514       445/598
(74 %)
7 diff
(98.9 %id)
BE855534 brain, glioblastoma (pooled) .b 790 to 1214 425 to 1       425/425
(100 %)
0 diff
(100 %id)
DB515377 testis .b 802 to 1227 1 to 428     Submitted on the opposite strand 428/429
(99 %)
10 diff
(97.7 %id)
AW969772   .b 820 to 1213 484 to 91     Submitted on the opposite strand 394/603
(65 %)
0 diff
(100 %id)
AA491530 Ewing's sarcoma .b 820 to 1206 387 to 1       387/394
(98 %)
3 diff
(99.3 %id)
AL571598 placenta, Placenta Cot 25-normalized .b 853 to 1200 351 to 1   fully sequenced,   351/351
(100 %)
9 diff
(97.5 %id)
AI751341 Bone, Hip .b 873 to 1248 384 to 8   tiling clone,   377/384
(98 %)
0 diff
(100 %id)
AK057925   .c 1 to 729 744 to 16 exact tiling clone, available from FLJ, AAA Submitted on the opposite strand 729/729
(100 %)
0 diff
(100 %id)
AI885154 anaplastic oligodendroglioma, brain .c 182 to 721 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BF513679   .c 253 to 721 481 to 13   AAA   469/469
(100 %)
8 diff
(98.3 %id)
BG182733   .c 267 to 724 1 to 458       458/464
(98 %)
6 diff
(98.8 %id)
BU506898 leiomyosarcoma, uterus .d 1 to 844 1 to 849 exact tiling clone,   849/920
(92 %)
15 diff
(98.4 %id)
BG707816 brain, hypothalamus .e 1 to 783 1 to 782 exact     782/787
(99 %)
15 diff
(98.1 %id)
BC018086 Brain, hypothalamus .e 6 to 804 1 to 798 exact tiling clone, available from MGC, AAA   798/798
(100 %)
5 diff
(99.4 %id)
BP232166 muscle Gene CDKN2AIPNL, variant not shown         This clone was ignored    
AI800506 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene CDKN2AIPNL, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
BG615760 embryonal carcinoma, testis Gene CDKN2AIPNL, variant not shown         Suspected internal deletion, this clone was ignored    
BU169405 eye, retinoblastoma Gene CDKN2AIPNL, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a-u, .b, .c, .d, .e Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C